MRNA YTD Stock Return Of -39% Underperforms CVAC by -11% and Underperforms ALNY by -79%

Retrieved on: 2024-10-05 15:38:23

Tags for this article:

Click the tags to see associated articles and topics

MRNA YTD Stock Return Of -39% Underperforms CVAC by -11% and Underperforms ALNY by -79%. View article details on hiswai:

Excerpt

Moderna (MRNA) returned -39% YTD; MRNA underperformed CureVac by -11% (CVAC returned -28%). CVAC LTM revenue changed 18% vs.

Article found on: www.trefis.com